Critically ill patients that although typically presenting with pro-inflammatory conditions(SIRS),subsequently active compensatory anti-inflammatory response(CARS) characterized by elevated plasma levels of anti-inflammatory cytokines (e.g., IL-10) and a decreased ability of immune cells to respond appropriately to a new inflammatory challenge[37]. The gene discussed is IL10; the disease is systemic inflammatory response syndrome.